E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 3.1 EUR 0.85%
Market Cap: 296.3m EUR

Net Margin
Euroapi SAS

-14.2%
Current
-13%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-14.2%
=
Net Income
-125m
/
Revenue
882.8m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
FR
Euroapi SAS
PAR:EAPI
294.5m EUR
-14%
US
Eli Lilly and Co
NYSE:LLY
1T USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
515.3B USD
27%
CH
Roche Holding AG
SIX:ROG
258.6B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
211.7B GBP
16%
CH
Novartis AG
SIX:NOVN
208.5B CHF
26%
US
Merck & Co Inc
NYSE:MRK
249.4B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
33%
IE
Endo International PLC
LSE:0Y5F
209B USD
-126%
US
Pfizer Inc
NYSE:PFE
150.3B USD
16%
No Stocks Found

Euroapi SAS
Glance View

Market Cap
294.5m EUR
Industry
Pharmaceuticals

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

EAPI Intrinsic Value
7.6 EUR
Undervaluation 59%
Intrinsic Value
Price
E
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-14.2%
=
Net Income
-125m
/
Revenue
882.8m
What is the Net Margin of Euroapi SAS?

Based on Euroapi SAS's most recent financial statements, the company has Net Margin of -14.2%.

Back to Top